Letters

More financial resources must be provided for multidrug resistant TB

BMJ 1999; 318 doi: https://doi.org/10.1136/bmj.318.7190.1076a (Published 17 April 1999) Cite this as: BMJ 1999;318:1076
  1. Matthias L Schmid, Specialist registrar in infectious diseases (Matthias.Schmid@csuh-tr.trent.nhs.uk),
  2. Michael W McKendrick, Consultant physician,
  3. Stephen T Green, Consultant physician,
  4. Elisabeth J Ridgway, Consultant microbiologist
  1. North Trent Department of Infection and Tropical Medicine, Royal Hallamshire Hospital, Sheffield S10 2JF
  2. Department of Microbiology, Royal Hallamshire Hospital

    EDITOR—Drobniewski endorsed the need for the rational use of rapid diagnostic tools in the diagnosis of multidrug resistant tuberculosis.1 This model of rapid culture and sensitivity testing should become the rule rather than being the exception as at present. Only by making the earliest possible diagnosis can we achieve optimum management.

    In England and Wales in 1997 there were 5859 notifications of tuberculosis and 447 deaths from the disease; isolates of multidrug resistant tuberculosis reported to the Communicable …

    View Full Text

    Sign in

    Log in through your institution

    Subscribe